1. Yuan, Gang, Flores, Natasha M, Hausmann, Simone, Mazur, Pawel K, Gozani, Or. 2021. Elevated NSD3 histone methylation activity drives squamous cell lung cancer. In Nature, 590, 504-508. doi:10.1038/s41586-020-03170-y. https://pubmed.ncbi.nlm.nih.gov/33536620/
2. Jacques-Fricke, Bridget T, Roffers-Agarwal, Julaine, Hussein, Amina O, Gearhart, Micah D, Gammill, Laura S. 2021. Profiling NSD3-dependent neural crest gene expression reveals known and novel candidate regulatory factors. In Developmental biology, 475, 118-130. doi:10.1016/j.ydbio.2021.02.015. https://pubmed.ncbi.nlm.nih.gov/33705737/
3. Xiu, Siyu, Chi, Xiaowei, Jia, Zhenyu, Zhang, Liangren, Liu, Zhenming. 2023. NSD3: Advances in cancer therapeutic potential and inhibitors research. In European journal of medicinal chemistry, 256, 115440. doi:10.1016/j.ejmech.2023.115440. https://pubmed.ncbi.nlm.nih.gov/37182335/
4. Satpathy, Shankha, Krug, Karsten, Jean Beltran, Pierre M, Mani, D R, Gillette, Michael A. . A proteogenomic portrait of lung squamous cell carcinoma. In Cell, 184, 4348-4371.e40. doi:10.1016/j.cell.2021.07.016. https://pubmed.ncbi.nlm.nih.gov/34358469/
5. Topchu, Iuliia, Pangeni, Rajendra P, Bychkov, Igor, Karanicolas, John, Boumber, Yanis. 2022. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. In Cellular and molecular life sciences : CMLS, 79, 285. doi:10.1007/s00018-022-04321-2. https://pubmed.ncbi.nlm.nih.gov/35532818/
6. Xu, Chenxi, Meng, Fanye, Park, Kwang-Su, Jin, Jian, Wang, Gang Greg. 2021. A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells. In Cell chemical biology, 29, 386-397.e9. doi:10.1016/j.chembiol.2021.08.004. https://pubmed.ncbi.nlm.nih.gov/34469831/
7. Nuñez, Yanara, Vera, Sebastian, Baeza, Victor, Gonzalez-Pecchi, Valentina. 2024. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions. In International journal of molecular sciences, 25, . doi:10.3390/ijms25020944. https://pubmed.ncbi.nlm.nih.gov/38256018/
智鼠故事 
